{"id":"https://openalex.org/W27937304","doi":null,"title":"Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate.","display_name":"Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate.","publication_year":2001,"publication_date":"2001-09-07","ids":{"openalex":"https://openalex.org/W27937304","mag":"27937304","pmid":"https://pubmed.ncbi.nlm.nih.gov/11698916"},"language":"en","primary_location":{"id":"pmid:11698916","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11698916","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MedGenMed : Medscape general medicine","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005161381","display_name":"James L. Schaller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J L Schaller","raw_affiliation_strings":["Chester County Research Center, Chester Springs, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chester County Research Center, Chester Springs, Pennsylvania, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026804701","display_name":"Glenn A. Burkland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G A Burkland","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.8835,"has_fulltext":false,"cited_by_count":105,"citation_normalized_percentile":{"value":0.96424567,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"3","issue":"5","first_page":"9","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12600","display_name":"Eosinophilic Disorders and Syndromes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12600","display_name":"Eosinophilic Disorders and Syndromes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imatinib-mesylate","display_name":"imatinib mesylate","score":0.9950000047683716},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.9819999933242798},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.9160000085830688},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.628000020980835},{"id":"https://openalex.org/keywords/headache","display_name":"headache","score":0.6990000009536743},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.8379999995231628},{"id":"https://openalex.org/keywords/treatment-remission","display_name":"treatment remission","score":0.4729999899864197},{"id":"https://openalex.org/keywords/eosinophilic-disorders","display_name":"eosinophilic disorders","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2779084869","wikidata":"https://www.wikidata.org/wiki/Q505142","display_name":"Hypereosinophilia","level":3,"score":0.9226301908493042},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.9124292135238647},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8621855974197388},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.5641336441040039},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.4330676198005676},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37100887298583984},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.36905723810195923},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3385794758796692},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.22122842073440552},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16321709752082825},{"id":"https://openalex.org/C2777129736","wikidata":"https://www.wikidata.org/wiki/Q505142","display_name":"Eosinophilia","level":2,"score":0.08000242710113525},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006918","descriptor_name":"Hydroxyurea","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017681","descriptor_name":"Hypereosinophilic Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:11698916","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11698916","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MedGenMed : Medscape general medicine","raw_type":"Case Reports"},{"id":"mag:27937304","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11698916","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2413543408","https://openalex.org/W2007010630","https://openalex.org/W2401134793","https://openalex.org/W2019070364","https://openalex.org/W2037558459","https://openalex.org/W1982659189","https://openalex.org/W1978330466","https://openalex.org/W2157556012","https://openalex.org/W2531774308","https://openalex.org/W7135854535"],"abstract_inverted_index":{"In":[0,49],"this":[1,50],"case":[2,13],"report,":[3],"we":[4,7,58],"report":[5],"what":[6],"believe":[8,59],"to":[9,96],"be":[10],"the":[11,35,88],"first":[12],"of":[14,23,90,100,111],"imatinib":[15,101],"mesylate":[16],"or":[17],"STI-571":[18],"(Novartis)":[19],"use":[20,104],"for":[21],"treatment":[22],"idiopathic":[24],"hypereosinophilia":[25],"syndrome":[26],"(HES).":[27],"HES":[28,112],"is":[29,44],"often":[30,45],"a":[31,73,98,114],"fatal":[32],"illness,":[33],"damaging":[34],"heart,":[36],"nervous":[37],"system,":[38],"lungs,":[39],"liver,":[40],"and":[41,57,79,86],"kidneys.":[42],"It":[43],"treated":[46],"with":[47,55,117],"interferon-alpha.":[48],"patient,":[51],"it":[52,60],"was":[53,105],"combined":[54],"hydroxyurea,":[56],"saved":[61],"his":[62],"life.":[63],"However,":[64],"he":[65],"experienced":[66],"many":[67],"common":[68],"side":[69,92,120],"effects,":[70],"such":[71],"as":[72],"profound":[74],"intractable":[75],"headache,":[76],"severe":[77],"fatigue,":[78],"concentration":[80],"difficulties.":[81],"After":[82],"years":[83],"on":[84],"hydroxyurea":[85],"interferon-alpha,":[87],"severity":[89],"these":[91],"effects":[93],"motivated":[94],"us":[95],"try":[97],"trial":[99],"mesylate.":[102],"Its":[103],"followed":[106],"by":[107],"an":[108],"abrupt":[109],"remission":[110],"in":[113],"few":[115],"weeks,":[116],"no":[118],"significant":[119],"effects.":[121]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}